May 8, 2020
Cambridge, UK and Indianapolis, US – 8 May 2020: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces...
Danish pathologists have performed the first three of a total of 300 post-mortem examinations. The objective is to provide new information about a wide range of aspects of COVID-19 over the coming months. The Lundbeck Foundation is one of the funding providers. How can we prepare as well as possible for the next pandemic? The...


Brain stimulation to relieve symptoms of Parkinson’s disease
25. January 2021
Mini-Brains to shed light on nervous disorders
25. January 2021
Mechanisms of schizophrenia
25. January 2021


Lundbeckfonden Ventures

Lundbeckfonden Emerge